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Onchocerciasis (river blindness) still poses a threat to public health in 
many tropical regions of Africa and Latin America, despite the 
concerted effort and high expenditure on control programmes 
(Basanez et al. 2002). So far, the control measures that have been 
implemented were aimed at interrupting transmission of the 
Onchocerca volvulus (Hougard et al. 1997) parasite either by 
eradicating the vector or the parasite. Davies (1994) made a 
comprehensive review of 60 years of onchocerciasis control world-
wide and the only record of vector eradication was in Kenya where 
Simulium neavei was successfully eradicated by mechanical 
vegetation removal and chemical larviciding (McMahon et al. 1958). 
The Kenyan situation however, has been faced with the problem of 
vector reinvasion from adjacent areas not covered by the exercise 
(Davies 1994). 
 
The advent of ivermectin for the treatment of human onchocerciasis 
and its suitability for large-scale application were major break-throughs 
in the control of human onchocerciasis through chemotherapy (Boatin 
et al. 1998). Its effectiveness in controlling the morbidity of the disease 
has been severally demonstrated (De Sole et al. 1989, Remme et al. 
1989, 1990, Abanobi & Anosike, 2000, Borsboom et al. 2003). 
Perhaps the successes recorded made Winnen et al. (2002) to predict 
that it is possible to eliminate onchocerciasis in Africa using control 
strategies based exclusively on ivermectin mass treatments requiring a 
period of at least 25 years in areas with medium to high levels of 
infection and annual mass treatments with 65% coverage. This has led 
to the closing down of the Onchocerciasis Control Program (OCP) in 
West Africa at the end of 2002 and transferring all subsequent control 
to the participating countries which will almost entirely be based on 




The impact of repeated mass treatment with ivermectin on the prevalence of onchocerciasis in Galadimawa, Kaduna State, 
Nigeria, was assessed. The 1988 pre-ivermectin treatment baseline data was compared with the 12 years post-ivermectin mass 
treatment prevalence of clinical manifestations of the disease (1989-2001) obtained in January 2002. The Rapid 
Epidemiological Assessment (REA) method was used to determine the prevalence of palpable nodules as an alternative to the 
more invasive skin snipping. From the 1988 pre-control data, 717 persons were examined of which 176 (24.5 %) had nodules. 
Parasitological confirmation by skin snipping of the same individuals revealed 346 (48.3 %) persons with Onchocerca volvulus 
microfilaria. In 2002, 700 persons were examined by REA alone, of which 53 (7.6 %) had nodules. Prevalence reduction post-
ivermectin mass treatment was significant for palpable nodules (p<0.001) and blindness (p=0.0014). Females had insignificant 
higher prevalences in all the clinical manifestations than males, except for hanging groin which was absent in the females both 
in1988 and 2002. Nodule prevalence correlated positively and significantly with age (r=0.91, p=0.005) and was significantly 
associated with adult females (p<0.01), contrary to reported findings in other communities where nodule prevalence was 
associated with adult males. 
  
Key words: Impact assessment, ivermectin, onchocerciasis, nodules, prevalence. 
 
 
The classical method of determining the prevalence and intensity of 
onchocercal infection is by the demonstration and counting of the O. 
volvulus microfilariae in biopsies obtained by skin snipping (Boatin et 
al. 1998). This technique is however becoming increasingly 
unacceptable because of its invasive nature and the risk it poses as a 
means for the spreading of the Human Acquired Immune Deficiency 
Syndrome (AIDS) virus. The demonstration of and excellent correlation 
between the prevalence of palpable nodules in a community and the 
microfilarial load has led to the development of Rapid Epidemiological 
Mapping of Onchocerciasis (REMO), which is geographical and the 
Rapid Epidemiological Assessment (REA), which is community based. 
These methods are rapid, safe and non-invasive that have enabled the 
identification of communities for mass treatment with ivermectin 
(Gemade et al. 1998, Esum et al. 2001, Anosike et al. 2001). The 
community based REA method involves the physical examination of 
individuals for the clinical manifestations of the disease, which include 
palpable nodules, skin depigmentation (leopard skin), hanging groin 
and blindness. Of these clinical signs, palpable nodules are the most 
sensitive for the determination of onchocercal infection (Vivas-Martinez 
et al. 2000). 
 
In this paper, the REA method was used to determine the prevalence 
of onchocerciasis in the study community before and after 12 years of 
repeated treatment with the drug aimed at assessing the impact of its 
 use in controlling the transmission of the disease in the area. 
 
MATERIALS AND METHODS 
Study area: Galadimawa is a village in Kauru Local Government Area 
of Kaduna State, Nigeria, approximately 65 Km drive westwards from 
Pambegua off the Kaduna-Jos road (10o39’N 8o30’E). Its population 
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dosing figure of 907persons of 1988 and Nigeria’s population annual 
growth rate of 4.0% (Encarta Premium  2007). The major occupation 
of the people in this village is farming, which is a predisposing factor to 
biting simuliids. 
 
Baseline data: The study was carried out within two weeks in June 
2002. Base-line data for onchocerciasis prevalence during the pre-
ivermectin dosing period as well as records of ivermectin distribution 
activities in the study area were obtained from the National Eye Center 
and Sight Savers both located in Kaduna. Other relevant information 
was obtained from the Departments of Biological Sciences, ABU Zaria 
and the Ophthalmology Unit, Ahmadu Bello University Teaching 
Hospital ABU, Zaria, Nigeria. These were used in establishing the 
prevalence of onchocerciasis in the study community before the 
commencement of the distribution of the drug in 1989. 
 
Collection of main data: A community-based questionnaire was 
designed and used for the assessment of the prevalence of the 
disease in the community using REA method (Gemade et al. 1998, 
Esum et al. 2001, Anosike et al. 2001). The parameters recorded 
included sex, marital status, and occupation. Five community health 
workers were used for the examination of members of the community 
and the administration of the questionnaires. Individuals were 
examined for clinical manifestations, namely: nodules, leopard skin, 




The 1988 pre-control baseline data showed that a total of 717 persons 
were examined both by the REA and parasitological (skin snipping) 
methods. Of these, 340 were males and 377 females. The REA 
method used showed that 222 (30.96 %) of the total persons 
examined had at least one of the clinical manifestations known to be 
prevalent in populations that are endemic for onchocerciasis. Palpable 
nodules was the  most prevalent clinical manifestation found on 176 
(24.45 %) persons. 25(3.49 %) persons were blind, 17(2.37 %) had 
leopard skin and hanging groin was the least prevalent found on only 4 
(0.56 %) of the persons. The prevalence of the disease determined 
parasitologically by the examination of skin snips obtained from the 
same persons examined by REA showed that 346(48.26%) were 
positive for O. volvulus microfilaria (Table 1). Females had a higher 
prevalence of 190 (50.40 %) compared to males with 156 (45.88 %), 
but the difference was not significant (χ2=1.28, p=0.26) 
 
Twelve years post-ivermectin mass treatment: Of the 700 persons 
examined in 2002 by REA, 81(11.57%) had at least one of the four 
physical manifestations of the disease with palpable nodules having 
the highest prevalence 53(7.57 %). Hanging groin was the least rare 
and found in only 4 persons (0.57%). The comparisons between the 
pre- and post-control prevalences as determined by REA are shown in 
Table 1. Females had higher prevalences than males for all the clinical 
manifestations except hanging groin which was absent in the females. 
These differences were not significant for both study periods. 
 
TABLE 1: THE PRE- AND POST-CONTROL PREVALENCES OF THE CLINICAL MANIFESTATIONS DETERMINED BY  






Number (%) of persons positive for each clinical manifestation 













Nodules 63(18.53) 113(29.97) 176(24.55) 15(4.27) 38(10.87) 53(7.57) 
Blindness 11(3.24) 14(3.71) 25(3.49) 2(0.57) 4(1.15) 6(0.86) 
Leopard skin 5(1.45) 12(3.18) 17(2.37) 6(1.17) 12(3.44) 18(6.61) 
Hanging groin 4(1.18) 0(0.00) 4(0.56) 4(1.14) 0(0.00) 4(0.57) 
Microfilaria 156(48.88) 190(50.40) 346(48.26) - - - 
 
 Prevalence reduction 12 years post ivermectin mass treatment was 
highly significant for palpable nodules (χ2=74.08, p<0.001) and 
blindness (χ2=10.25, p=0.0014) but no significant change in the 
prevalences for leopard skin (χ2=0.01, p=0.94) and hanging groin 
(χ2=0.10, p=0.75). 
 
From the 1998 pre-control data, the prevalence of palpable nodules 
(24.45%) was close to the actual prevalence of infection as determined 
by microfilarial emergence (48.26%) from skin snips. This was 
therefore the clinical manifestation used in 2002 to assess the disease 
burden in the study community as the alternative to skin snipping. 
 
 
The distribution of nodules in the community, based on the 
questionnaire showed that females had the highest prevalence 
(10.89%) of palpable nodules. This group was closely followed by 
those who were singles (10.36%) and farmers (8.94%) with sexes 
combined in both categories. The least prevalence of 4.14% was 
recorded in the married category (Table 2). Also, the Odd’s Ratio (OR) 
analysis showed that prevalence of palpable nodules was significantly 
associated with the female sex, those who were singles and farmers 
(OR>1.0, p<0.01). On the other hand, nodule prevalence showed no 
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TABLE 2: THE 2002 DISTRIBUTION OF PALPABLE NODULES AMONG VARIOUS  







Prevalence (%) Odds Ratio p-value 
Males 351 15 4.27 0.37 0.9985 
Females 349 38 10.59 2.74 0.0016 
*Married 314 13 4.14 0.37 0.9969 
*Singles 386 40 10.36 2.68 0.0032 
*Farmers 369 36 9.68 1.96 0.0358 
*Civil 
servants 
32 2 6.25 0.81 0.9579 
*Pupils 154 9 5.84 0.71 0.4563 

































FIG. 1: AGE CORRELATION WITH NODULE PREVALENCE IN GALADIMAWA AS DETERMINED  
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There was a significant positive correlation (r=0.9075, p=0.005) in the 
prevalence of nodules with age (Fig. 1) indicating that the prevalence 
of nodules increased with the ages of individuals examined. A slight 
insignificant decrease (χ2=0.04, p=0.85) in prevalence was observed 




The observed significant reduction in the prevalence of palpable 
nodules after the intervention with ivermectin was an indication of the 
efficacy of the drug in curbing the spread of onchocerciasis in the 
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reported earlier (Emuka et al. 2004, Ndyonmugyenyi et al. 2004). 
Although palpable nodules is a clinical condition that has been 
confirmed to be a valid rapid assessment tool for the community 
diagnosis of the disease for urgent distribution of ivermectin (Kipp & 
Bamhuhiiga 2002), it may not be absolutely adequate in the 
assessment of the efficacy of the drug in the control of onchocerciasis 
in some communities. This is because Emukah et al. (2004), in 
assessing the impact of repeated mass ivermectin treatment on the 
clinical manifestations of onchocerciasis in Imo state, Nigeria, found 
that nodule prevalence in one community did not change at all seven 
years post commencement of ivermectin treatment. 
 
The females in the study community were more disposed to infection 
with the disease than their male counterpart. This is because the 
women are involved in farming activities that span long hours daily, 
thereby exposing them to the repeated bites of the flies. This explains 
why nodule prevalence was significantly associated with farming being 
the main occupation in the study area. Therefore, the use of the 
prevalence of palpable nodules in adult males as a rapid method for 
the identification of communities that are hyperendemic for 
onchocerciasis as determined by earlier workers (Law et al. 1998, 
Whitworth & Gemade 1999, Kipp & Bamhuhiiga 2002) may not be 
suitable for application in this study community. Adult females in this 
case will be the most suitable. We also suggest that the cultural and 
agricultural practices of each community should be taken into 
consideration during pre-ivermectin treatment surveys. 
 
Although the prevalence of nodule reduced significantly post-
ivermectin repeated mass treatment, it still correlated strongly and 
positively with age. Higher nodule prevalences in the adult population 
agree with previous works (Anosike et al. 2001). 
 
Previous reports (Winnen et al. 2002) showed that the efficacy of 
ivermectin in controlling the disease burden of any community 
depends on the consistency of the treatment regimen. Osei-
Atweneboana et al. (2007) demonstrated in Ghana that skin 
microfilaria repopulation commenced in 12-90% of treated individuals 
in the various communities they studied. Therefore, intervals between 
treatment regimens beyond 90 days (3 months) may still allow the 
effective transmission of the parasite by the simuliid vector. 
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